Crinetics Pharmaceuticals Inc.
Clinical trials sponsored by Crinetics Pharmaceuticals Inc., explained in plain language.
-
New drug shows promise for rare hormone disorder
Disease control CompletedThis study tested a new drug called CRN04894 in 38 adults with classic congenital adrenal hyperplasia, a condition where the body can't make certain hormones properly. The goal was to see if the drug could safely lower abnormal hormone levels and reduce the need for high-dose ste…
Phase: PHASE2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New pill shows promise for rare Cancer-Related diarrhea
Symptom relief CompletedThis study tested a new pill called paltusotine in 36 adults with carcinoid syndrome, a condition that can cause flushing and diarrhea due to certain tumors. The goal was to see if the drug is safe and how the body processes it at different doses. Participants received either 40 …
Phase: PHASE2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Symptom relief
Last updated May 26, 2026 08:55 UTC
-
New drug atumelnant passes early safety check in healthy people
Knowledge-focused CompletedThis early-stage study tested the safety and how the body processes a new drug called atumelnant in 21 healthy adults (Japanese and Caucasian). Participants received either the drug or a placebo. The goal was to measure drug levels and check for side effects, not to treat any dis…
Phase: PHASE1 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC